<DOC>
	<DOCNO>NCT01335633</DOCNO>
	<brief_summary>The study entail cognitive assessment single cohort patient Multiple Sclerosis . Each subject assess twice , approximately 45 day apart . There intervention control group . Each participant caregiver capable respond brief report observation regard neuropsychological skill abilities patient .</brief_summary>
	<brief_title>Psychometric Validation Cognitive Endpoints</brief_title>
	<detailed_description />
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>18 65 year old ( inclusive ) . History RelapsingRemitting Secondary Progressive Multiple Sclerosis Physically able see test material complete test Have family member caregiver capable consent willing complete MSNQInformant questionnaire . A history treat untreated severe mental illness diagnosis major depression prior MS onset . Untreated major depression untreated anxiety disorder . History Attention Deficit/Hyperactivity Disorder , Developmental Learning Disorder include Mental Retardation . History traumatic brain injury intracranial bleed , stroke , Alzheimer 's disease , Parkinson 's disease , Motor Coordination Disorder neurologic illness . I understand Investigator believe would interfere successful completion protocol , I exclude . A clinically significant relapse within past 2 month . I serious infection ( e.g. , pneumonia , septicemia ) within 2 month . History drug alcohol abuse ( define Investigator ) within 1 year prior Study Day 1 . Active bacterial viral infection . Use marijuana within 2 month prior Study Day 1or time study Alcohol consumption within 24 hour either test session . Unable comply study requirement . Expected survival time le 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>MS</keyword>
	<keyword>Neuropsychological test</keyword>
</DOC>